Home Business Pre-increase!Northeast Pharmaceutical: Estimated net profit in the first three quarters of 2021 will be 24 million to 30 million yuan, a year-on-year increase of 2856.03% to 3,595.04% | Daily Business News

Pre-increase!Northeast Pharmaceutical: Estimated net profit in the first three quarters of 2021 will be 24 million to 30 million yuan, a year-on-year increase of 2856.03% to 3,595.04% | Daily Business News

by admin

Every AI newsletter,Northeast Pharmaceutical (SZ 000597, closing price: 5.34 yuan) issued a performance forecast on the evening of October 13, and it is expected that the net profit attributable to shareholders of listed companies in the first three quarters of 2021 will be 24 million to 30 million yuan, a year-on-year increase of 2856.03%~3595.04% ; Basic earnings per share from 0.0178 yuan to 0.0223 yuan.

1. Northeast Pharmaceutical’s shareholding of northbound funds decreased by 71,400 shares in the past 30 days, and the proportion of shares in circulation decreased by 0.00%;
2. No organization has conducted research on Northeast Pharmaceutical in the past 30 days.

(Reporter Wang Keran)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. According to this operation, at your own risk.

Copyright Notice

1This article is the original work of “Daily Economic News”.

2

Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, extracting, copying or creating mirror images, etc., offenders must be investigated.

3Copyright cooperation telephone: 021-60900099.

See also  One-hand net profit of 60,000 Hong Kong dollars, Times Angel soared 183% on the first day of listing, becoming the most profitable new stock | Hong Kong stocks_Sina Finance_Sina.com
0 comment
0

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy